secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0000097745-23-000054
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher Q2 revenue $10.69B (-3% YoY), GAAP EPS $3.51, cuts FY guidance
----------------------------------------------------------------------------

- Q2 revenue $10.69B, down 3% YoY; core organic growth +2%; COVID testing revenue $0.08B.
- GAAP diluted EPS $3.51 (vs $4.22 YoY); adjusted EPS $5.15 (vs $5.51 YoY).
- FY 2023 guidance revised: revenue $43.4-44.0B, core organic growth 2-4%, adj. EPS $22.28-22.72.
- Announced agreement to acquire CorEvitas for ~$0.9B post-quarter; adds real-world evidence solutions.
- CEO cites challenging macro, slower China spend; PPI Business System helping navigate environment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774523000054/0000097745-23-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774523000054/tmo-20230726.htm
  HTML page:      https://secwatch.observer/filing/0000097745-23-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer